Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $4.89.
DCGO has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Stifel Nicolaus cut their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Finally, Needham & Company LLC decreased their price objective on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th.
Get Our Latest Stock Analysis on DCGO
Institutional Inflows and Outflows
DocGo Stock Performance
Shares of DocGo stock opened at $2.64 on Tuesday. The stock has a 50 day moving average price of $4.00 and a 200-day moving average price of $3.91. DocGo has a one year low of $2.51 and a one year high of $5.68. The stock has a market cap of $269.24 million, a price-to-earnings ratio of 9.43, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
- Five stocks we like better than DocGo
- Election Stocks: How Elections Affect the Stock Market
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What Are Dividend Champions? How to Invest in the Champions
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- 3 Tickers Leading a Meme Stock Revival
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.